115 related articles for article (PubMed ID: 3495005)
61. Early events during the activation of human lymphocytes by the mitogenic monoclonal antibody OKT3.
Walls EV; Borghetti AF; Benzie CR; Kay JE
Cell Immunol; 1984 Nov; 89(1):30-8. PubMed ID: 6548415
[TBL] [Abstract][Full Text] [Related]
62. Tumor-cell lysis by in-situ-activated human peripheral-blood mononuclear cells.
Smans KA; Hoylaerts MF; Hendrickx HF; Goergen MJ; De Broe ME
Int J Cancer; 1991 Feb; 47(3):431-8. PubMed ID: 1993552
[TBL] [Abstract][Full Text] [Related]
63. Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3.
Tsoukas CD; Fox RI; Carson DA; Fong S; Vaughan JH
Cell Immunol; 1982 May; 69(1):113-21. PubMed ID: 6286147
[No Abstract] [Full Text] [Related]
64. The mitogenic activity of OKT3 and anti-Leu 4 monoclonal antibodies: a comparative study.
Van Wauwe JP; Goossens JG
Cell Immunol; 1983 Apr; 77(1):23-9. PubMed ID: 6687702
[TBL] [Abstract][Full Text] [Related]
65. Mitogenic actions of Orthoclone OKT3 on human peripheral blood lymphocytes: effects of monocytes and serum components.
Van Wauwe J; Goossens J
Int J Immunopharmacol; 1981; 3(3):203-8. PubMed ID: 7287264
[TBL] [Abstract][Full Text] [Related]
66. Induction of human complement activation without cytolysis by mouse monoclonal antibodies to human leukocyte antigens.
Sugita K; Majdic O; Stockinger H; Holter W; Burger R; Knapp W
Transplantation; 1987 Apr; 43(4):570-4. PubMed ID: 3576673
[TBL] [Abstract][Full Text] [Related]
67. Investigation of human T-cell biology with monoclonal antibodies.
Kung PC
J Cutan Pathol; 1983 Dec; 10(6):457-66. PubMed ID: 6420450
[No Abstract] [Full Text] [Related]
68. Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule.
AboT ; Tilden AB; Balch CM; Kumagai K; Troup GM; Cooper MD
J Exp Med; 1984 Jul; 160(1):303-9. PubMed ID: 6429266
[TBL] [Abstract][Full Text] [Related]
69. The importance of T3 in the activation of T lymphocytes.
Beverley P
Nature; 1983 Aug 4-10; 304(5925):398-9. PubMed ID: 6603576
[No Abstract] [Full Text] [Related]
70. Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.
Zalman LS; Brothers MA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4827-31. PubMed ID: 3260383
[TBL] [Abstract][Full Text] [Related]
71. Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli.
Garcia-Sanz JA; Velotti F; MacDonald HR; Masson D; Tschopp J; Nabholz M
Immunology; 1988 May; 64(1):129-34. PubMed ID: 3260214
[TBL] [Abstract][Full Text] [Related]
72. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.
Jung G; Ledbetter JA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4611-5. PubMed ID: 3110771
[TBL] [Abstract][Full Text] [Related]
73. Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.
Martin DE; Zalman LS; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):213-7. PubMed ID: 2963326
[TBL] [Abstract][Full Text] [Related]
74. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.
Smyth MJ; Ortaldo JR; Shinkai Y; Yagita H; Nakata M; Okumura K; Young HA
J Exp Med; 1990 Apr; 171(4):1269-81. PubMed ID: 1691263
[TBL] [Abstract][Full Text] [Related]
75. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
Hideshima T; Okada N; Okada H
Immunology; 1990 Mar; 69(3):396-401. PubMed ID: 1690178
[TBL] [Abstract][Full Text] [Related]
76. Enhancement by monocytes of perforin production and its gene expression by human CD8+ T cells stimulated with interleukin-2.
Sugihara K; Sone S; Shono M; Nii A; Munekata M; Okumura K; Ogura T
Jpn J Cancer Res; 1992 Nov; 83(11):1223-30. PubMed ID: 1362428
[TBL] [Abstract][Full Text] [Related]
77. Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.
Martin DE; Zalman LS; Jung G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 May; 84(9):2946-50. PubMed ID: 3495005
[TBL] [Abstract][Full Text] [Related]
78. The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells.
Zalman LS; Martin DE; Jung G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2426-9. PubMed ID: 3494251
[TBL] [Abstract][Full Text] [Related]
79. The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.
Müller-Eberhard HJ
Immunol Rev; 1988 Mar; 103():87-98. PubMed ID: 3292398
[TBL] [Abstract][Full Text] [Related]
80. Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.
Zalman LS; Brothers MA; Chiu FJ; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5262-6. PubMed ID: 3460090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
